NanoRepro transforms into a multi-brand health platform post-pandemic, with strong growth potential from its diverse portfolio and M&A. Initiating coverage with a BUY and € 4.3 price target.
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
NanoRepro transforms into a multi-brand health platform post-pandemic, with strong growth potential from its diverse portfolio and M&A. Initiating coverage with a BUY and € 4.3 price target.
